Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The therapeutic index of newer H1-receptor antagonists.

× No keyword cloud information.

7 in total

Review 1. Cetirizine: a review of its use in children with allergic disorders.

Authors: C M Spencer; S Noble
Journal: Paediatr Drugs Date: 1999 Jan-Mar Impact factor: 3.022

Review 2. Comparative tolerability of second generation antihistamines.

Authors: F Horak; U P Stübner
Journal: Drug Saf Date: 1999-05 Impact factor: 5.606

3. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function.

Authors: I Hindmarch; Z Shamsi; N Stanley; D B Fairweather
Journal: Br J Clin Pharmacol Date: 1999-08 Impact factor: 4.335

Review 4. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.

Authors: L R Wiseman; D Faulds
Journal: Drugs Date: 1996-02 Impact factor: 9.546

5. Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects.

Authors: A Patat; D Stubbs; C Dunmore; N Ulliac; B Sexton; I Zieleniuk; A Irving; W Jones
Journal: Eur J Clin Pharmacol Date: 1995 Impact factor: 2.953

6. Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg: a double-blind, randomised study in patients with perennial allergic rhinitis.

Authors: R J Davies
Journal: Clin Drug Investig Date: 1998 Impact factor: 2.859

7. Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.

Authors: Hiroyuki Kamei; Ami Isaji; Yukihiro Noda; Kazuhiro Ishikawa; Koji Senzaki; Kiyofumi Yamada; Kazumitsu Sugiura; Yasushi Tomita; Toshitaka Nabeshima
Journal: Arch Dermatol Res Date: 2011-12-01 Impact factor: 3.017

7 in total